|
Pfizer more than doubles price of Covid-19 medication Paxlovid, shortages in poorer countries |
mike kraft |
Group Post |
10/19/23 |
|
Pfizer official expects updated COVID-19 vaccine data for kids under 5 by April |
mike kraft |
Group Post |
01/05/22 |
|
Pfizer plans to submit data on a 4th Covid shot to FDA |
mike kraft |
Group Post |
03/14/22 |
|
Pfizer reports its COVID-19 vaccine trial data shows long-term efficacy in adolescents |
mike kraft |
Group Post |
11/22/21 |
|
Pfizer requests emergency authorization for its oral antiviral COVID-19 treatment |
mike kraft |
Group Post |
11/16/21 |
|
Pfizer says booster in children 5-11 raises antibodies against omicron |
FNUOvviyaa |
Group Post |
04/14/22 |
|
Pfizer says COVID treatment Paxlovid fails to prevent spread of infection of household members |
mike kraft |
Group Post |
04/29/22 |
|
Pfizer says COVID-19 vaccine more than 90% effective in kids |
mike kraft |
Group Post |
10/22/21 |
|
Pfizer says early data signals COVID-19 vaccine is effective |
mike kraft |
Group Post |
11/09/20 |
|
Pfizer says it is ready to launch RSV vaccines for older adults, pregnant women |
mike kraft |
Group Post |
03/09/23 |
|
Pfizer Says It Won’t Seek Vaccine Authorization Before Mid-November |
mike kraft |
Group Post |
10/16/20 |
|
Pfizer says its COVID-19 vaccine is safe, effective in kids ages 5 to 11 |
mike kraft |
Group Post |
09/20/21 |
|
Pfizer says its new antiviral pill cuts risk of severe COVID-19 by 89% |
mike kraft |
Group Post |
11/05/21 |
|
Pfizer says testing shows booster restores full protection against COVID-19 |
mike kraft |
Group Post |
10/21/21 |
|
Pfizer says tests show its vaccine is effective against the South African variant |
mike kraft |
Group Post |
04/01/21 |
|
Pfizer seeks FDA approval of updated COVID vaccine booster retooled for Omcron |
mike kraft |
Group Post |
08/22/22 |
|
Pfizer shots protect kids from severe COVID even in omicron --new data |
mike kraft |
Group Post |
03/01/22 |
|
Pfizer signs agreement to allow broader global access to its experimental Covid-19 antiviral pill |
mike kraft |
Group Post |
11/16/21 |
|
Pfizer speeds up its vaccine delivery after J&J pause |
mike kraft |
Group Post |
04/14/21 |
|
Pfizer starts late-stage trial of mRNA-based flu vaccine |
mike kraft |
Group Post |
09/15/22 |
|
Pfizer study estimates its vaccine helped prevent over 110,000 Covid deaths |
mike kraft |
Group Post |
05/16/22 |
|
Pfizer study shows COVID-19 booster can be given along with pneumonia shot |
mike kraft |
Group Post |
01/12/22 |
|
Pfizer submits data to FDA for use of its Covid vaccine for children ages 5 to 11 |
mike kraft |
Group Post |
09/28/21 |
|
Pfizer to offer low-cost medicines, vaccines to poor nations |
mike kraft |
Group Post |
05/25/22 |
|
Pfizer to seek authorization for 2nd Covid booster for people 65 and older |
mike kraft |
Group Post |
03/15/22 |
|
Pfizer to seek OK for 3rd, booster shot, to extend protection |
mike kraft |
Group Post |
07/08/21 |
|
Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states |
mike kraft |
Group Post |
11/17/20 |
|
Pfizer to study using booster shot aimed at virus variant |
mike kraft |
Group Post |
02/25/21 |
|
Pfizer to supply up to 6 million COVID pill courses for lower income countries |
mike kraft |
Group Post |
09/22/22 |
|
Pfizer to test COVID-19 vaccine for children under 12 |
mike kraft |
Group Post |
06/08/21 |
|
Pfizer vaccine efficacy reported to decline in Israel as delta variant spreads |
mike kraft |
Group Post |
07/05/21 |
|
Pfizer vaccine highly effective in real-world study, Israeli researchers say |
mike kraft |
Group Post |
02/25/21 |
|
Pfizer vs Moderna vaccines: What we know, and what we don't |
mike kraft |
Group Post |
11/16/20 |
|
Pfizer's child-sized vaccine fails to produce expected immunity in younger kids; company adds third dose to trials |
mike kraft |
Group Post |
12/17/21 |
|
Pfizer's COVID vaccine 73.2% effective in kids under 5-- new data |
mike kraft |
Group Post |
08/23/22 |
|
Pfizer's Covid vaccine safe in people with prior myocarditis--French study |
mike kraft |
Group Post |
03/17/22 |
|
Pfizer's COVID-19 vaccine supply to the EU 30% below plans, sources say |
mike kraft |
Group Post |
02/17/21 |
|
Pfizer's says its updated COVID shot is effective against 'Eris' variant in mice study |
mike kraft |
Group Post |
08/18/23 |
|
Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US |
mike kraft |
Group Post |
11/20/20 |
|
Pfizer, BioNTech request FDA full approval of their Covid-19 vaccine |
mike kraft |
Group Post |
05/07/21 |
|
Pfizer, BioNTech say COVID-19 booster shot showed high 95.6% efficacy in large study |
mike kraft |
Group Post |
10/21/21 |
|
Pfizer, BioNTech say updated vaccines offer ‘substantially higher immune response’ against omicron |
mike kraft |
Group Post |
06/27/22 |
|
Pfizer, BioNTech's updated booster protects against Omicron in human trial |
mike kraft |
Group Post |
10/13/22 |
|
Pfizer, Moderna seek authorization for updated Covid-19 boosters for younger children |
mike kraft |
Group Post |
09/28/22 |
|
Pfizer, US sign $5.29B deal for possible COVID-19 pill treatment |
mike kraft |
Group Post |
11/18/21 |
|
Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates |
mike kraft |
Group Post |
01/20/21 |
|
Pfizer-BioNTech expected to seek authorization for coronavirus booster for people 18 and older |
mike kraft |
Group Post |
11/08/21 |
|
Pfizer-BioNTech vaccine effective for children under 5: FDA staff |
FNUOvviyaa |
Group Post |
06/13/22 |
|
Pfizer-BioNTech vaccine not affected by mutation seen in contagious coronavirus variant, study indicates |
mike kraft |
Group Post |
01/08/21 |
|
Pfizer/ BioNTech seek FDA authorization for Covid-19 vaccine booster for all adults |
mike kraft |
Group Post |
11/09/21 |
Recent Comments